Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Sarcoma 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Neoplasms 3 Melanoma 3 Colonic Neoplasms 3 Thymoma 2 Rectal Neoplasms 2 Primary Myelofibrosis 2 Pancreatic Neoplasms 2 Myeloproliferative Disorders 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Leukemia, Myelomonocytic, Chronic 2 Esophageal Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1

Interventions

Cyclophosphamide 32 Filgrastim 18 Irinotecan 15 Topotecan 14 Temozolomide 13 Vincristine 12 Peripheral Blood Stem Cell Transplantation 12 Granulocyte Colony-Stimulating Factor 12 Etoposide 12 Melphalan 11 fludarabine 10 Carboplatin 9 dinutuximab 8 Isotretinoin 8 Interleukin-2 8 Busulfan 8 humanized 3F8 anti-GD2 monoclonal antibody 7 aldesleukin 7 Doxorubicin 7 3-Iodobenzylguanidine 7 sargramostim 6 fludarabine phosphate 6 Vorinostat 6 Zoledronic Acid 5 Stem Cell Transplantation 5 Cisplatin 5 etoposide phosphate 4 Ipilimumab 4 Drug Therapy 4 ribociclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neuroblastoma × Celecoxib × Clear all

NCT02030964 2025-02-17

DFMO

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡